Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320.
Publication
, Journal Article
Kenny, A; van Duijn, J; Dintwe, O; Heptinstall, J; Burnham, R; Sawant, S; Zhang, L; Mielke, D; Khuzwayo, S; Omar, FL; Stanfield-Oakley, S ...
Published in: EBioMedicine
September 2025
Duke Scholars
Published In
EBioMedicine
DOI
EISSN
2352-3964
Publication Date
September 2025
Volume
119
Start / End Page
105874
Location
Netherlands
Related Subject Headings
- 4202 Epidemiology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kenny, A., van Duijn, J., Dintwe, O., Heptinstall, J., Burnham, R., Sawant, S., … Imbokodo Study and Correlates Group. (2025). Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320. EBioMedicine, 119, 105874. https://doi.org/10.1016/j.ebiom.2025.105874
Kenny, Avi, Janine van Duijn, One Dintwe, Jack Heptinstall, Randy Burnham, Sheetal Sawant, Lu Zhang, et al. “Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320.” EBioMedicine 119 (September 2025): 105874. https://doi.org/10.1016/j.ebiom.2025.105874.
Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, Sawant S, et al. Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320. EBioMedicine. 2025 Sep;119:105874.
Kenny, Avi, et al. “Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320.” EBioMedicine, vol. 119, Sept. 2025, p. 105874. Pubmed, doi:10.1016/j.ebiom.2025.105874.
Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, Sawant S, Zhang L, Mielke D, Khuzwayo S, Omar FL, Stanfield-Oakley S, Keyes T, Dunn B, Goodman D, Fong Y, Benkeser D, Zou R, Hural J, Hyrien O, Juraska M, Luedtke A, van der Laan L, Giorgi EE, Magaret C, Carpp LN, Pattacini L, van de Kerkhof T, Korber B, Willems W, Fisher LH, Schuitemaker H, Swann E, Kublin JG, Pau MG, Buchbinder S, Tomaka F, Nijs S, Lavreys L, Gelderblom HC, Corey L, Mngadi K, Gray GE, Borducchi E, Hendriks J, Seaton KE, Zolla-Pazner S, Barouch DH, Ferrari G, De Rosa SC, McElrath MJ, Andersen-Nissen E, Stieh DJ, Tomaras GD, Gilbert PB, Imbokodo Study and Correlates Group. Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320. EBioMedicine. 2025 Sep;119:105874.
Published In
EBioMedicine
DOI
EISSN
2352-3964
Publication Date
September 2025
Volume
119
Start / End Page
105874
Location
Netherlands
Related Subject Headings
- 4202 Epidemiology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences